Patients with mixed connective tissue disease (MCTD, n=32) 
In patients with SLE Dw3 and DR3 were increased with the highest relative risks. Of the antigens associated with these two, B8 was increased very significantly, but the increase in the Al antigen was less obvious. An increase in Awl9 and a decrease in B35 and Dwl were also seen.
The group of patients with MCTD clearly differed from those with SLE. The frequencies of DR3 and associated antigens were similar in the control subjects. The HLA-Dw4 antigen was increased, and the frequencies of DR4 and B16 differed significantly from those of control subjects. Ten of the 11 DR4 positive patients with MCTD had Dw4, but only one had Dwl4, 'which is the second MLC defined specificity associated with DR4 which is frequent in Finland. The overall frequency of Dwl4 was the same in patients with MCTD and SLE and in control subjects. The association of MCTD with the Dw4 subset of DR4 is also seen in table 4, in which risks for antigen combinations are presented. The frequencies of several other HLA antigens differed significantly between patients with MCTD and those with SLE: A3, B35, Cw4, Dw4, and DR4 were increased and B8 and DR3 were decreased in patients with MCTD compared with those with SLE.
Discussion
In this work we analysed types of HLA antigens in 32 patients with MCTD and 60 with SLE to answer two questions: (1) are there any HLA associations with MCTD, and (2) are there genetic differences between patients with MCTD and SLE? The answer to both questions was positive. The frequencies of HLA antigens in MCTD were similar to those in control subjects, with the exception of an increased frequency of HLA-Dw4 (10/22 (45%) in patients with MCTD, 34/192 (18%) in control subjects, uncorrected p=0 006). The frequencies of DR4 and B16 were also slightly increased (p<005). In both control subjects and patients with SLE the frequency of the Dw4 subtype of DR4 was much lower than it was in patients with MCTD, halfof whom carried Dw4. Previously well known HLA associations with SLE were also seen here. Al, B8, Dw3, and DR3 were increased.6-9 11 12 16 17 Dw2 and DR2 frequencies in our patients with SLE were lower than reported previously6 10 13-17 and also lower than in our controls. It has been proposed that both DR2 and DR3 antigens might be markers for immune hyper-responsiveness, i.e. increased seroreactivity (anti-Ro, anti-DNA, RF, and hyperglobulinaemia),'5 thus our patients with SLE would have an antibody pattern different from, for example, American or Japanese series.'3 Other differences between patients with SLE and control subjects were an increase in the frequency of Awl9, also reported by Stastny, 30 and 
